Although further studies are needed to clarify the biological significance of degradation of the HCV core protein in the HCV lifecycle in greater detail, SPP might serve as a novel drug target for chronic hepatitis C through the inhibition of HCV core protein maturation. Here, HM13 is linked to chronic hepatitis C virus infection.